Skip to content

Comparition of transcutaneous electrical nerve stimulation and epidural analgesia in labour pain

Comparition effect of transcutaneous electrical nerve stimulation and epidural analgesia with lidocaine 1% on pain and prognosis of labour

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013071610841N5
Enrollment
105
Registered
2016-04-23
Start date
2014-07-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delivery. Spontaneous vertex delivery

Interventions

Intervention 1: In Epidural group ,Epidural catheter is placed in active phase of labour(cervical dilation=5cm) and 10 ml lidocaine %1plus 1ml sufentanil is injected.In secondary stage,maximum 15 ml
Prevention
Placebo
In Epidural group ,Epidural catheter is placed in active phase of labour(cervical dilation=5cm) and 10 ml lidocaine %1plus 1ml sufentanil is injected.In secondary stage,maximum 15 ml lidocaine %1is i
In TENS group two pairs electrodes are placed in T0-L1&S2-S4 nerve roots. In first and second stages of labour electrodes connected to TENS device and set by 10-18 MA stimulation and 100 HZ frequenc
In control group, any methods of analgesia is used but TENS electrodes are placed .

Sponsors

Vice chancellor for research Hamadan University Of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Voluntarily participate in research; candidate for vaginal delivery; fetus cephalic presentation;term pregnancy;uncomplicated pregnancy;patients in active phase with >5cm dilation of cervix Exclusion criteria: Cutaneous infection in back region (urticaria, insects and scar); previous cesarean section; patients with pacemaker;contraindications of epidural analgesia(couagolopathy ,hypovolemia,region cutaneous infection,increasing ICP and anemia)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Labour pain. Timepoint: 5-10-15 and30 minutes after analgesia. Method of measurement: visual analgesic scale.;Labour progress. Timepoint: labour duration. Method of measurement: duration of first and second stages of labour.;Heart Rate. Timepoint: 5-10-15 and30 minutes after analgesia. Method of measurement: nomber of heart rate per minute.;Systolic and diastolic blood presure. Timepoint: 5-10-15 and30 minutes after analgesia. Method of measurement: non invasive bloon presure monitoring.;Tempreture. Timepoint: 5-10-15 and30 minutes after analgesia. Method of measurement: Termometer.;New born Apgar. Timepoint: 1&5 minutes after delivery. Method of measurement: Apgar Score.;Satisfactory. Timepoint: After delivery. Method of measurement: questioning.;Cesarean Section. Timepoint: Duration of labour. Method of measurement: Observation.

Secondary

MeasureTime frame
Nausea & vomiting. Timepoint: during &after delivery. Method of measurement: Observation.;Itching. Timepoint: during &after delivery. Method of measurement: Observation &visual scale.;Respiratory Depression. Timepoint: during &after delivery. Method of measurement: Respiratory rate & Spo2.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Nahid Manouchehrian

Hamadan University of Medical Science-Fatemie Hospital

manouchehrian@umsha.ac.irmanuchehriann@gmail.com+98 81 3827 7012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026